137 related articles for article (PubMed ID: 33118606)
1. Performance of monocyte activation test supplemented with human serum compared to fetal bovine serum.
Molenaar-de Backer MWA; Gitz E; Dieker M; Doodeman P; Ten Brinke A
ALTEX; 2021; 38(2):307-315. PubMed ID: 33118606
[TBL] [Abstract][Full Text] [Related]
2. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens.
Solati S; Zhang T; Timman S
Innate Immun; 2022 Apr; 28(3-4):130-137. PubMed ID: 35491666
[TBL] [Abstract][Full Text] [Related]
3. Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin.
Perdomo-Morales R; Pardo-Ruiz Z; Spreitzer I; Lagarto A; Montag T
ALTEX; 2011; 28(3):227-35. PubMed ID: 21993958
[TBL] [Abstract][Full Text] [Related]
4. Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.
Gimenes I; Caldeira C; Presgrave OA; de Moura WC; Villas Boas MH
Regul Toxicol Pharmacol; 2015 Oct; 73(1):356-60. PubMed ID: 26232706
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery.
Thurman TL; Lahti CJ; Mateffy JM; Forng RY; von Wintzingerode F; Silva LM; Deutschmann SM; Mozier N
ALTEX; 2023; 40(1):117-124. PubMed ID: 35796330
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT).
da Silva CC; Presgrave OA; Hartung T; de Moraes AM; Delgado IF
Toxicol In Vitro; 2016 Apr; 32():70-5. PubMed ID: 26688320
[TBL] [Abstract][Full Text] [Related]
7. Validation of the monocyte activation test with three therapeutic monoclonal antibodies.
Daniels R; Van der Elst W; Dieltjens N; Appels T; So CK; Nys T; Voeten L; Breugelmans P; Molenaar-de Backer MWA; Gitz E; Poole S; Patel M
ALTEX; 2022; 39(4):621–635. PubMed ID: 35502618
[TBL] [Abstract][Full Text] [Related]
8. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products.
Kim JH; Jung K; Kim J; Lee J; Kim H; Song H; Han K; Park S; Ahn C; Kim CW
Biologicals; 2021 Jun; 71():20-30. PubMed ID: 33994086
[TBL] [Abstract][Full Text] [Related]
9. An improved monocyte activation test using cryopreserved pooled human mononuclear cells.
Solati S; Aarden L; Zeerleder S; Wouters D
Innate Immun; 2015 Oct; 21(7):677-84. PubMed ID: 25907070
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine.
Etna MP; Giacomini E; Rizzo F; Severa M; Ricci D; Shaid S; Lambrigts D; Valentini S; Galli Stampino L; Alleri L; Gaggioli A; Von Hunolstein C; Spreitzer I; Coccia EM
ALTEX; 2020; 37(4):532-544. PubMed ID: 32488289
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
[TBL] [Abstract][Full Text] [Related]
12. Pyrogen detection methods: comparison of bovine whole blood assay (bWBA) and monocyte activation test (MAT).
Wunderlich C; Schumacher S; Kietzmann M
BMC Pharmacol Toxicol; 2014 Sep; 15():50. PubMed ID: 25209100
[TBL] [Abstract][Full Text] [Related]
13. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
Borton LK; Coleman KP
ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
[TBL] [Abstract][Full Text] [Related]
14. Using PBMCs in a Multiplex FluoroSpot Assay for Detection of Innate Immune Response-Modulating Impurities (IIRMIs).
Makower B; Ahlborg N
Methods Mol Biol; 2024; 2768():241-249. PubMed ID: 38502397
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test.
Hasiwa N; Daneshian M; Bruegger P; Fennrich S; Hochadel A; Hoffmann S; Rivera-Mariani FE; Rockel C; Schindler S; Spreitzer I; Stoppelkamp S; Vysyaraju K; Hartung T
ALTEX; 2013; 30(2):169-208. PubMed ID: 23665806
[TBL] [Abstract][Full Text] [Related]
16. A comparison of pyrogen detection tests in the quality control of meningococcal conjugate vaccines: The applicability of the Monocyte Activation Test.
Fernandes Silva V; da Silva Guedes Junior D; da Silveira IA; Santos Almeida A; de Paiva Conte F; Fernandes Delgado I; Caldeira Silva C; França Presgrave OA; Antunes de Mattos K
Altern Lab Anim; 2018 Nov; 46(5):255-272. PubMed ID: 30488711
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens.
Andrade SS; Silveira RL; Schmidt CA; Júnior LB; Dalmora SL
Int J Pharm; 2003 Oct; 265(1-2):115-24. PubMed ID: 14522124
[TBL] [Abstract][Full Text] [Related]
18. Leukoreduction system chambers provide a valuable source of functional monocytes for the monocyte activation test by comparison with internationally validated methods.
Nordgren IK
J Immunol Methods; 2016 Jan; 428():42-9. PubMed ID: 26678159
[TBL] [Abstract][Full Text] [Related]
19. Pyrogen testing revisited on occasion of the 25th anniversary of the whole blood monocyte activation test.
Hartung T
ALTEX; 2021; 38(1):3-19. PubMed ID: 33452528
[TBL] [Abstract][Full Text] [Related]
20. Using the monocyte activation test as a stand-alone release test for medical devices.
Brown J; Clippinger AJ; Fritz Briglia C; Casey W; Coleman K; Fritsch A; Hartung T; Maouyo D; Muller T; Reich J; Robert L; Roeder R; Sanchez G; Sawyer AY; Solati S; Tirumalai R; Zwisler W; Allen D
ALTEX; 2021; 38(1):151-156. PubMed ID: 33452530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
